DENTIPATCH Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dentipatch, and when can generic versions of Dentipatch launch?
Dentipatch is a drug marketed by Noven and is included in one NDA.
The generic ingredient in DENTIPATCH is lidocaine. There are twenty-nine drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the lidocaine profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dentipatch
A generic version of DENTIPATCH was approved as lidocaine by ACTAVIS LABS UT INC on August 23rd, 2012.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for DENTIPATCH?
- What are the global sales for DENTIPATCH?
- What is Average Wholesale Price for DENTIPATCH?
Summary for DENTIPATCH
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 104 |
| Patent Applications: | 4,640 |
| DailyMed Link: | DENTIPATCH at DailyMed |
US Patents and Regulatory Information for DENTIPATCH
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Noven | DENTIPATCH | lidocaine | FILM, EXTENDED RELEASE;BUCCAL | 020575-001 | May 21, 1996 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Noven | DENTIPATCH | lidocaine | PATCH;TOPICAL | 020575-002 | May 21, 1996 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for DENTIPATCH
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Noven | DENTIPATCH | lidocaine | FILM, EXTENDED RELEASE;BUCCAL | 020575-001 | May 21, 1996 | ⤷ Start Trial | ⤷ Start Trial |
| Noven | DENTIPATCH | lidocaine | PATCH;TOPICAL | 020575-002 | May 21, 1996 | ⤷ Start Trial | ⤷ Start Trial |
| Noven | DENTIPATCH | lidocaine | FILM, EXTENDED RELEASE;BUCCAL | 020575-001 | May 21, 1996 | ⤷ Start Trial | ⤷ Start Trial |
| Noven | DENTIPATCH | lidocaine | FILM, EXTENDED RELEASE;BUCCAL | 020575-001 | May 21, 1996 | ⤷ Start Trial | ⤷ Start Trial |
| Noven | DENTIPATCH | lidocaine | PATCH;TOPICAL | 020575-002 | May 21, 1996 | ⤷ Start Trial | ⤷ Start Trial |
| Noven | DENTIPATCH | lidocaine | PATCH;TOPICAL | 020575-002 | May 21, 1996 | ⤷ Start Trial | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for DENTIPATCH
See the table below for patents covering DENTIPATCH around the world.
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Ireland | 64436 | Breathable backing | ⤷ Start Trial |
| Australia | 1521295 | ⤷ Start Trial | |
| Japan | H06508820 | ⤷ Start Trial | |
| Israel | 102277 | Dermal composition comprising a plurality of polymers and which modulates the permeation rate of a drug contained therein | ⤷ Start Trial |
| Singapore | 43349 | Method and apparatus for forming a transdermal drug device | ⤷ Start Trial |
| South Korea | 100363052 | ⤷ Start Trial | |
| Canada | 2104474 | COMPOSITIONS ET METHODES POUR L'ADMINISTRATION TOPIQUE D'AGENTS PHARMACEUTIQUES ACTIFS (COMPOSITIONS AND METHODS FOR TOPICAL ADMINISTRATION OF PHARMACEUTICALLY ACTIVE AGENTS) | ⤷ Start Trial |
| >Country | >Patent Number | >Title | >Estimated Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch